• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲CCR5基因32碱基对缺失的分布情况。

Distribution of the CCR5 gene 32-bp deletion in Europe.

作者信息

Lucotte G, Mercier G

机构信息

Neurology Department, Maison Blanche Hospital, Rheims, France.

出版信息

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):174-7. doi: 10.1097/00042560-199810010-00011.

DOI:10.1097/00042560-199810010-00011
PMID:9768627
Abstract

The chemokine receptor CCR5 constitutes the major coreceptor for the macrophage-tropic strains of HIV-1. A mutant allele of the CCR5 gene called delta32 was shown to provide strong resistance to homozygotes against infection by HIV. The frequency of the delta32 allele was investigated in 2522 noninfected unrelated individuals from 16 different European populations. The delta32 allele was found in all populations studied, with a mean frequency of about 9.1%. A north-to-south gradient correlating latitude with delta32 allelic frequencies was found (r = 0.726), with highest allele frequencies in Denmark and Northern France, and the lowest allele frequencies in Corsica.

摘要

趋化因子受体CCR5是HIV-1巨噬细胞嗜性毒株的主要共受体。CCR5基因的一个名为delta32的突变等位基因被证明能为纯合子提供强大的抗HIV感染能力。在来自16个不同欧洲人群的2522名未感染的无关个体中,对delta32等位基因的频率进行了调查。在所研究的所有人群中均发现了delta32等位基因,平均频率约为9.1%。发现了一个将纬度与delta32等位基因频率相关联的由北向南的梯度(r = 0.726),丹麦和法国北部的等位基因频率最高,科西嘉岛的等位基因频率最低。

相似文献

1
Distribution of the CCR5 gene 32-bp deletion in Europe.欧洲CCR5基因32碱基对缺失的分布情况。
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):174-7. doi: 10.1097/00042560-199810010-00011.
2
Distribution of the CCR5 gene 32-basepair deletion in West Europe. A hypothesis about the possible dispersion of the mutation by the Vikings in historical times.西欧CCR5基因32碱基对缺失的分布。关于该突变在历史时期可能由维京人传播的一种假说。
Hum Immunol. 2001 Sep;62(9):933-6. doi: 10.1016/s0198-8859(01)00292-0.
3
Distribution of 32 alelle of the CCR5 gene in the population of Poland.CCR5基因32等位基因在波兰人群中的分布。
J Hum Genet. 2000;45(5):271-4. doi: 10.1007/s100380070014.
4
The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe.在高加索人群中赋予对HIV-1保护作用的deltaccr5突变在欧洲东北部有单一且近期的起源。
Hum Mol Genet. 1998 Mar;7(3):399-406. doi: 10.1093/hmg/7.3.399.
5
More about the Viking hypothesis of origin of the delta32 mutation in the CCR5 gene conferring resistance to HIV-1 infection.关于CCR5基因中赋予对HIV-1感染抗性的delta32突变起源的维京假说的更多内容。
Infect Genet Evol. 2003 Nov;3(4):293-5. doi: 10.1016/j.meegid.2003.07.001.
6
Distribution of the CCR5 gene 32-base pair deletion in Israeli ethnic groups.
J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):81-4. doi: 10.1097/00042560-199901010-00012.
7
Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.埃及人和叙利亚人中HIV耐药CCR5-Delta32等位基因的分布情况。
Mutat Res. 2007 Mar 1;616(1-2):175-80. doi: 10.1016/j.mrfmmm.2006.11.024. Epub 2006 Dec 12.
8
CCR5-Delta32 allele frequencies in Ashkenazi Jews.德系犹太人中CCR5-Δ32等位基因频率。
Genet Test. 2003 Winter;7(4):333-7. doi: 10.1089/109065703322783716.
9
Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish and Northern European population samples.基于犹太人和北欧人群样本单倍型变异的CCR5基因Delta32突变的演变
Hum Immunol. 2001 May;62(5):530-8. doi: 10.1016/s0198-8859(01)00239-7.
10
CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.C-C趋化因子受体5 Δ32多态性:巴基斯坦皮肤利什曼病患者的关联分析及等位基因分布
J Cutan Pathol. 2016 Jul;43(7):564-70. doi: 10.1111/cup.12712. Epub 2016 Apr 6.

引用本文的文献

1
CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.CCR5 作为人类免疫缺陷病毒和猴免疫缺陷病毒的核心受体:一种典型的爱恨情仇关系。
Front Immunol. 2022 Jan 27;13:835994. doi: 10.3389/fimmu.2022.835994. eCollection 2022.
2
Human Genomic Loci Important in Common Infectious Diseases: Role of High-Throughput Sequencing and Genome-Wide Association Studies.在常见传染病中起重要作用的人类基因组位点:高通量测序和全基因组关联研究的作用
Can J Infect Dis Med Microbiol. 2018 Mar 20;2018:1875217. doi: 10.1155/2018/1875217. eCollection 2018.
3
Host genetic variation and HIV disease: from mapping to mechanism.
宿主基因变异与HIV疾病:从定位到机制
Immunogenetics. 2017 Aug;69(8-9):489-498. doi: 10.1007/s00251-017-1000-z. Epub 2017 Jul 10.
4
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.国际基础和临床药理学联合会。[更正]。LXXXIX. 趋化因子受体大家族的更新及为非典型趋化因子受体引入新的命名法。
Pharmacol Rev. 2013 Nov 11;66(1):1-79. doi: 10.1124/pr.113.007724. Print 2014.
5
Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection.趋化因子受体基因的序列变异与HIV-1感染易感性
J Appl Genet. 2009;50(2):159-66. doi: 10.1007/BF03195668.
6
Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequencies?猫免疫缺陷病毒人畜共患病是否会导致群落失调,从而降低欧洲CCR5-Δ32等位基因频率?
Virol J. 2008 Oct 16;5:119. doi: 10.1186/1743-422X-5-119.
7
Association study of CCR5 delta 32 polymorphism among the HLA-DRB1 Caucasian population in Northern Paraná, Brazil.巴西巴拉那州北部白种人群中CCR5基因第32位密码子缺失多态性与HLA-DRB1的关联性研究
J Clin Lab Anal. 2008;22(4):229-33. doi: 10.1002/jcla.20225.
8
Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals.CCR5-Δ32杂合性在一组意大利异性恋HIV-1暴露未感染个体中的部分保护作用。
AIDS Res Ther. 2006 Sep 25;3:22. doi: 10.1186/1742-6405-3-22.
9
The geographic spread of the CCR5 Delta32 HIV-resistance allele.CCR5基因Δ32型HIV抗性等位基因的地理分布。
PLoS Biol. 2005 Nov;3(11):e339. doi: 10.1371/journal.pbio.0030339. Epub 2005 Oct 18.
10
Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2.CCR5在针对2型单纯疱疹病毒的抗病毒宿主防御中的年龄依赖性作用。
J Virol. 2005 Aug;79(15):9831-41. doi: 10.1128/JVI.79.15.9831-9841.2005.